Molecular Epidemiology and Genotyping of Mycobacterium tuberculosis Isolated in Baghdad
Table 2
Orphan strains () and corresponding spoligotyping defined lineages/sublineages recorded among a total of 270 M. tuberculosis strains (one isolate per patient) from Iraqi patients.
Iso number
Year
Strain
Spoligotype description
Octal code
Lineage*
Label
Drug R**
Isolation city
Sex/age
IRQ02201004351
2010
4351
677777377413771
EAI5
O01
0
Wasit
F/60
IRQ02201023876
2010
3876
703767740003071
CAS1-Delhi
O02
2
Baghdad
M/29
IRQ02201015527
2010
5527
037727777760771
T3
O03
1
Babil
F/29
IRQ02201003954
2010
3954
037657777741770
Unknown
O04
0
Baghdad
M/22
IRQ02201113313
2011
3313
437727777760771
T3
O05
1
Sulaimaniya
M/35
IRQ02201114243
2011
4243
537637777760771
T1
O06
1
Baghdad
F/35
IRQ02201014888
2010
4888
177767377400671
Unknown
O07
1
Diyala
M/33
IRQ02201016952
2010
6952
577777777520771
H3
O08
1
Baghdad
M/35
IRQ02201017197
2010
7197
557727777400771
Unknown
O09
1
Baghdad
M/39
IRQ02201115282
2011
5282
757767740003171
Unknown
O10
1
Baghdad
M/35
IRQ02201115448
2011
5448
757777740763771
Manu2
O11
1
Diyala
M/63
IRQ02201013167
2010
3167
703627400003771
CAS
O12
1
Baghdad
F/16
IRQ02201003924
2010
3924
703637400003771
CAS
O13
0
Baghdad
M/48
IRQ02201005145
2010
5145
477767607760771
LAM1
O14
0
Najaf
F/35
IRQ02201004981
2010
4981
557747607740661
LAM9
O15
0
Dhi-qar
M/37
IRQ02201025861
2010
5861
637737777760771
T3
O16
2
Al-Qadisiya
M/29
IRQ02201026647
2010
6647
777767636760771
T1
O17
2
Basra
F/29
IRQ02201015057
2010
5057
777764077760771
T1
O18
1
Baghdad
M/47
IRQ02201024897b
2010
4897b
677767377413771
EAI5
O19
2
Basra
M/21
IRQ02201024258
2010
4258
503767740003761
CAS1-Delhi
O20
2
Baghdad
M/54
IRQ02201014287
2010
4287
777727777420771
H3 (Ural-1)
O21
1
Dhi-qar
F/51
IRQ02201016432
2010
6432
775767600760771
T1
O22
1
Baghdad
M/60
IRQ02201014433
2010
4433
503667700003771
CAS
O23
1
Babil
M/23
IRQ02201016038
2010
6038
757767637763771
Manu2
O24
1
Baghdad
M/28
IRQ02201013391
2010
3391
777727777000771
Unknown
O25
1
Baghdad
M/31
IRQ02201113592
2011
3592
503767400001771
CAS
O26
1
Baghdad
M/21
IRQ02201113234
2011
3234
777767777722771
Manu2
O27
1
Dhi-qar
M/40
IRQ02201004179
2010
4179
677767637563771
Manu2
O28
0
Baghdad
M/25
IRQ02201016082
2010
6082
777766607760771
LAM9
O29
1
Baghdad
F/24
IRQ02201103164
2011
3164
777766637760771
X1
O30
0
Baghdad
M/24
IRQ02201012729
2010
2729
701767700003071
CAS
O31
1
Dhi-qar
M/65
IRQ02201015095
2010
5095
403767400001771
Unknown
O32
1
Najaf
M/70
IRQ02201014584
2010
4584
577767777520771
H3
O33
1
Baghdad
F/18
IRQ02201004326
2010
4326
777767770000771
Unknown
O34
0
Baghdad
M/25
IRQ02201113543
2011
3543
501767740003071
CAS
O35
1
Baghdad
M/22
IRQ02201026360b
2010
6360b
577767600760771
T1
O36
2
Basra
M/35
IRQ02201014885
2010
4885
577737777520771
H3
O37
1
Baghdad
M/29
IRQ02201026915
2010
6915
743767740003171
Unknown
O38
2
Salah
M/37
IRQ02201015996
2010
5996
757767400741771
Unknown
O39
1
Baghdad
M/20
IRQ02201014761
2010
4761
500000000000000
CAS
O40
1
Baghdad
F/56
IRQ02201113275
2011
3275
703767400003071
CAS
O41
1
Salah
M/30
IRQ02201004309
2010
4309
503767740003000
CAS1-Delhi
O42
0
Salah
M/37
IRQ02201016005
2010
6005
757767777720771
H3
O43
1
Baghdad
F/54
IRQ02201123429
2011
3429
501727740003071
CAS
O44
2
Baghdad
M/53
IRQ02201113672
2011
3672
703767740000171
CAS
O45
1
Dhi-qar
M/58
IRQ02201017297
2010
7297
703727740003111
CAS1-Delhi
O46
1
Kerbala
M/24
IRQ02201013852
2010
3852
703767740003661
CAS1-Delhi
O47
1
Baghdad
M/20
IRQ02201015137
2010
5137
575767737760671
T1
O48
1
Baghdad
M/25
IRQ02201012104
2010
2104
757777744743771
Unknown
O49
1
Dhi-qar
M/65
IRQ02201013811
2010
3811
757767777743771
Unknown
O50
1
Baghdad
F/35
IRQ02201113484
2011
3484
577727777420771
H4 (Ural-2)
O51
1
Baghdad
F/53
IRQ02201112326
2011
2326
557767777743771
Unknown
O52
1
Dhi-qar
M/56
IRQ02201016511
2010
6511
555727604643071
Unknown
O53
1
Wasit
M/30
Lineage designations for orphan patterns were done manually as expert-based interpretations using revised SpolDB4 rules.
**Drug resistance (drug R) information is shown as 0, unknown; 1, non-MDR; 2, MDRTB, that is, combined resistance to INH − RIF (with or without resistance to other drugs); 3, any other resistance(s); 4, proven XDRTB, that is, resistance to INH + RIF + a fluoroquinolone + any 1 of 3 injectable 2nd-line drugs (capreomycin, kanamycin, amikacin).
